Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lærke K. Tolstrup"'
Autor:
Helle Pappot, Gry Assam Taarnhøj, MD, Line Bentsen, Rasmus Blechingberg Friis, Christina Bæksted, Mille Guldager Christiansen, Cecilie Holländer-Mieritz, Pia Krause Møller, Ida Marie Lind Rasmussen, Trine Lund-Jacobsen, Dag Rune Stormoen, Lærke K. Tolstrup
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 24, Iss , Pp 23-30 (2024)
Introduction: Many studies using Patient-reported outcomes (PRO) data have been conducted to monitor symptoms and health-related quality of life during follow-up after cancer treatment. However new ways of using (e)PROs have emerged. We aimed to expl
Externí odkaz:
https://doaj.org/article/728288b937dd4233a90765b72362b17a
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-8 (2022)
Abstract Introduction In a randomized controlled trial, we previously investigated if melanoma patients receiving checkpoint inhibitors had fewer severe immune-related adverse events (irAEs) when they reported symptoms using electronic patient-report
Externí odkaz:
https://doaj.org/article/21ae7d47c2334b45b096db18b328da83
Autor:
Lærke K. Tolstrup, Lars Bastholt, Karin B. Dieperink, Sören Möller, Ann-Dorthe Zwisler, Helle Pappot
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-10 (2020)
Abstract Background A randomized controlled pilot trial was conducted to assess if melanoma patients treated with immunotherapy had the number of grade 3 or 4 adverse events during treatment reduced by 50% using a tailored electronic patient-reported
Externí odkaz:
https://doaj.org/article/c84a95b48b324f7998a9e9cf5e88b88b
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-7 (2019)
Abstract Context Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients r
Externí odkaz:
https://doaj.org/article/8f44d3cf0b2b4be5a4371e6e9f0e6b16
Autor:
Lærke K. Tolstrup, Helle Pappot, Graziella Zangger, Lars Bastholt, Ann-Dorthe Zwisler, Karin B. Dieperink
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Aim No suitable Danish questionnaire exists to evaluate patient satisfaction with various patient reported outcome measures. Thus, the aim of this research project was to conduct a study on the translation and cultural adaption of an America
Externí odkaz:
https://doaj.org/article/c2d0c5d425f942009190033ad1cd1f55
Autor:
Sidsel Pedersen, Rikke B. Holmstroem, Annika von Heymann, Laerke K. Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A. Haslund, Christina H. Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek
Publikováno v:
Pedersen, S, Holmstroem, R B, von Heymann, A, Tolstrup, L K, Madsen, K, Petersen, M A, Haslund, C A, Ruhlmann, C H, Schmidt, H, Johansen, C, Svane, I M & Ellebaek, E 2023, ' Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy ', Acta Oncologica, vol. 62, no. 1, pp. 62-69 . https://doi.org/10.1080/0284186X.2023.2165449
Introduction: Treatment with immune checkpoint inhibitors (ICI) has expanded into the adjuvant setting enhancing the importance of knowledge on the immune-related toxicities and their impact on health-related quality of life (HRQoL). Large phase 3 tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c0ca32e1a4701d7dcc58552112dd2d
https://vbn.aau.dk/da/publications/4b006f36-9c3c-49fd-b6c4-1a35936b4627
https://vbn.aau.dk/da/publications/4b006f36-9c3c-49fd-b6c4-1a35936b4627
Publikováno v:
Journal of Patient-Reported Outcomes
Tolstrup, L K, Pappot, H, Bastholt, L, Möller, S & Dieperink, K B 2022, ' Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors : health-related quality of life among melanoma patients in a randomized controlled trial ', Journal of patient-reported outcomes, vol. 6, 8 . https://doi.org/10.1186/s41687-022-00414-5
Tolstrup, L K, Pappot, H, Bastholt, L, Möller, S & Dieperink, K B 2022, ' Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors : health-related quality of life among melanoma patients in a randomized controlled trial ', Journal of Patient-Reported Outcomes, vol. 6, no. 1, 8 . https://doi.org/10.1186/s41687-022-00414-5
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-8 (2022)
Tolstrup, L K, Pappot, H, Bastholt, L, Möller, S & Dieperink, K B 2022, ' Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors : health-related quality of life among melanoma patients in a randomized controlled trial ', Journal of patient-reported outcomes, vol. 6, 8 . https://doi.org/10.1186/s41687-022-00414-5
Tolstrup, L K, Pappot, H, Bastholt, L, Möller, S & Dieperink, K B 2022, ' Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors : health-related quality of life among melanoma patients in a randomized controlled trial ', Journal of Patient-Reported Outcomes, vol. 6, no. 1, 8 . https://doi.org/10.1186/s41687-022-00414-5
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-8 (2022)
Introduction In a randomized controlled trial, we previously investigated if melanoma patients receiving checkpoint inhibitors had fewer severe immune-related adverse events (irAEs) when they reported symptoms using electronic patient-reported outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe54471f93f00dac40de68761afc6dd
https://pubmed.ncbi.nlm.nih.gov/35061112
https://pubmed.ncbi.nlm.nih.gov/35061112
BACKGROUND The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fc59c65b449b37c4461eb93a57b1f4
https://doi.org/10.2196/preprints.14896
https://doi.org/10.2196/preprints.14896